Watch Dr. Neil Buckholtz, Director of the Division of Neuroscience at the National Institute on Aging/NIH, describe how biomarkers—in blood, cerebrospinal fluid and brain imaging—are advancing our ability to detect the earliest stages of Alzheimer’s, track its progression, and determine the effectiveness of promising treatments.
*Video Produced by the National Institute on Aging at NIH
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Services
Platforms